Samsara Biocapital, LLC
24 holdingsFiling period: 2026-06-30Current AUM: $930.7Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Hldg Corp | 6.90M | $379.4M | $293.1M | 31.49% | -- | 2026-06-30 |
| 2 | ALMS | Alumis Inc | 6.35M | $178.6M | $42.1M | 4.53% | -- | 2026-06-30 |
| 3 | MLYS | Mineralys Therapeutics Inc | 5.87M | $158.4M | $124.1M | 13.33% | -- | 2026-06-30 |
| 4 | SEPN | Septerna Inc | 3.15M | $105.5M | $139.0M | 14.94% | -- | 2026-06-30 |
| 5 | ALMR | Alamar Biosciences Inc | 2.48M | $67.2M | $79.2M | 8.51% | -- | 2026-06-30 |
| 6 | NGNE | Neurogene Inc | 1.72M | $54.0M | $46.3M | 4.98% | -- | 2026-06-30 |
| 7 | KLRS | Kalaris Therapeutics Inc | 12.88M | $52.4M | $24.0M | 2.57% | -66,906 | 2026-06-30 |
| 8 | SGP | Spyglass Pharma Inc | 2.11M | $47.0M | $65.2M | 7.01% | -- | 2026-06-30 |
| 9 | STRO | Sutro Biopharma Inc | 1.06M | $35.3M | $9.4M | 1.01% | -- | 2026-06-30 |
| 10 | IVA | Inventiva SA | 6.31M | $23.9M | $23.3M | 2.50% | +1.12M | 2026-06-30 |
| 11 | JBIO | Jade Biosciences Inc | 736.2K | $16.4M | $10.9M | 1.17% | -232,561 | 2026-06-30 |
| 12 | PBLS | Parabilis Medicines Inc | 556.0K | $15.2M | $14.7M | 1.58% | -- | 2026-06-30 |
| 13 | VTVT | Vtv Therapeutics Inc | 298.5K | $11.2M | $7.7M | 0.82% | -- | 2026-06-30 |
| 14 | AQST | Aquestive Therapeutics Inc | 2.50M | $10.4M | $10.2M | 1.09% | -- | 2026-06-30 |
| 15 | NKTX | Nkarta Inc | 3.51M | $9.9M | $6.0M | 0.64% | -- | 2026-06-30 |
| 16 | ARTV | Artiva Biotherapeutics Inc | 954.9K | $9.3M | $4.1M | 0.44% | -- | 2026-06-30 |
| 17 | RANI | Rani Therapeutics Hldgs Inc | 10.37M | $7.9M | $6.3M | 0.68% | +1.87M | 2026-06-30 |
| 18 | AGMB | Agomab Therapeutics NV | 600.0K | $7.8M | $5.0M | 0.54% | -- | 2026-06-30 |
| 19 | ABVX | Abivax SA | 55.1K | $7.3M | $4.8M | 0.51% | -1,486 | 2026-06-30 |
| 20 | XFOR | X4 Pharmaceuticals Inc | 1.40M | $6.5M | $4.5M | 0.49% | -436,979 | 2026-06-30 |
| 21 | ELOX | Eloxx Pharmaceuticals Inc | 400.0K | $5.6M | $5.3M | 0.57% | -- | 2026-06-30 |
| 22 | CHRS | Coherus Oncology Inc | 3.43M | $4.8M | $3.7M | 0.39% | -- | 2026-06-30 |
| 23 | UPB | Upstream Bio Inc | 353.7K | $2.4M | $987K | 0.11% | -382,330 | 2026-06-30 |
| 24 | GOSS | Gossamer Bio Inc | 7.22M | $1.2M | $881K | 0.09% | -- | 2026-06-30 |
← Scroll →